
Conceivable Life Sciences
Conceivable Life Sciences: Automating IVF labs for accessible fertility treatments.

Conceivable Life Sciences: Automating IVF labs for accessible fertility treatments.
Conceivable Life Sciences was founded with the mission to democratize access to in vitro fertilization (IVF) by building the first fully automated IVF lab. The company's vision is to make the highest quality fertility treatments available to all, addressing the significant gap in accessibility. Conceivable Life Sciences focuses on leveraging advanced technology to overhaul traditional IVF processes, aiming to provide affordable and efficient fertility solutions to millions of people worldwide who struggle with infertility.
Notable figures affiliated with Conceivable Life Sciences include experts in reproductive medicine and technology innovation. The company has garnered attention from investors interested in healthcare and technological advancements. Key achievements include the development of proprietary automation technology that significantly reduces the cost and complexity of IVF procedures. The overall impact of Conceivable Life Sciences lies in its potential to transform the fertility treatment landscape, making it possible for a greater number of intended parents to realize their dreams of having children.
Companies similar to Conceivable Life Sciences include Tmrw Life Sciences, Overture Life, Incept BioSystems and INVO Fertility.
Conceivable Life Sciences was founded in 2022.
Conceivable Life Sciences' headquarters is located in New York City, NY, US.
Conceivable Life Sciences' most recent funding round was for $20M (USD) in August 2023.
As of Aug 1, 2023, Conceivable Life Sciences has disclosed funding of $20M (USD). Undisclosed round amounts are excluded.
Conceivable Life Sciences has 12 employees as of Feb 5, 2024.

INVO Fertility
invobioscience.com